Portopulmonary hypertension

A tale of two circulations

Rohit Budhiraja, Paul M Hassoun

Research output: Contribution to journalArticle

Abstract

Pulmonary involvement is common in patients with portal hypertension and can manifest in diverse manners. Changes in pulmonary arterial resistance, manifesting either as the hepatopulmonary syndrome or portopulmonary hypertension (PPHTN), have been increasingly recognized in these patients in recent years. This review summarizes the clinicopathologic features, diagnostic criteria, as well as the latest concepts in the pathogenesis and management of PPHTN, which is defined as an elevated pulmonary artery pressure in the setting of an increased pulmonary vascular resistance and a normal wedge pressure in a patient with portal hypertension.

Original languageEnglish (US)
Pages (from-to)562-576
Number of pages15
JournalChest
Volume123
Issue number2
DOIs
StatePublished - Feb 1 2003

Fingerprint

Portal Hypertension
Hypertension
Hepatopulmonary Syndrome
Lung
Pulmonary Wedge Pressure
Vascular Resistance
Pulmonary Artery
Pressure

Keywords

  • Endothelin
  • Liver
  • Nitric oxide
  • Portal hypertension
  • Portopulmonary hypertension
  • Prostacyclin
  • Pulmonary hypertension
  • Serotonin
  • Transplant

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Portopulmonary hypertension : A tale of two circulations. / Budhiraja, Rohit; Hassoun, Paul M.

In: Chest, Vol. 123, No. 2, 01.02.2003, p. 562-576.

Research output: Contribution to journalArticle

Budhiraja, Rohit ; Hassoun, Paul M. / Portopulmonary hypertension : A tale of two circulations. In: Chest. 2003 ; Vol. 123, No. 2. pp. 562-576.
@article{c4bf8b02d8bd4d8d8924d76857116ed9,
title = "Portopulmonary hypertension: A tale of two circulations",
abstract = "Pulmonary involvement is common in patients with portal hypertension and can manifest in diverse manners. Changes in pulmonary arterial resistance, manifesting either as the hepatopulmonary syndrome or portopulmonary hypertension (PPHTN), have been increasingly recognized in these patients in recent years. This review summarizes the clinicopathologic features, diagnostic criteria, as well as the latest concepts in the pathogenesis and management of PPHTN, which is defined as an elevated pulmonary artery pressure in the setting of an increased pulmonary vascular resistance and a normal wedge pressure in a patient with portal hypertension.",
keywords = "Endothelin, Liver, Nitric oxide, Portal hypertension, Portopulmonary hypertension, Prostacyclin, Pulmonary hypertension, Serotonin, Transplant",
author = "Rohit Budhiraja and Hassoun, {Paul M}",
year = "2003",
month = "2",
day = "1",
doi = "10.1378/chest.123.2.562",
language = "English (US)",
volume = "123",
pages = "562--576",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "2",

}

TY - JOUR

T1 - Portopulmonary hypertension

T2 - A tale of two circulations

AU - Budhiraja, Rohit

AU - Hassoun, Paul M

PY - 2003/2/1

Y1 - 2003/2/1

N2 - Pulmonary involvement is common in patients with portal hypertension and can manifest in diverse manners. Changes in pulmonary arterial resistance, manifesting either as the hepatopulmonary syndrome or portopulmonary hypertension (PPHTN), have been increasingly recognized in these patients in recent years. This review summarizes the clinicopathologic features, diagnostic criteria, as well as the latest concepts in the pathogenesis and management of PPHTN, which is defined as an elevated pulmonary artery pressure in the setting of an increased pulmonary vascular resistance and a normal wedge pressure in a patient with portal hypertension.

AB - Pulmonary involvement is common in patients with portal hypertension and can manifest in diverse manners. Changes in pulmonary arterial resistance, manifesting either as the hepatopulmonary syndrome or portopulmonary hypertension (PPHTN), have been increasingly recognized in these patients in recent years. This review summarizes the clinicopathologic features, diagnostic criteria, as well as the latest concepts in the pathogenesis and management of PPHTN, which is defined as an elevated pulmonary artery pressure in the setting of an increased pulmonary vascular resistance and a normal wedge pressure in a patient with portal hypertension.

KW - Endothelin

KW - Liver

KW - Nitric oxide

KW - Portal hypertension

KW - Portopulmonary hypertension

KW - Prostacyclin

KW - Pulmonary hypertension

KW - Serotonin

KW - Transplant

UR - http://www.scopus.com/inward/record.url?scp=0037332028&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037332028&partnerID=8YFLogxK

U2 - 10.1378/chest.123.2.562

DO - 10.1378/chest.123.2.562

M3 - Article

VL - 123

SP - 562

EP - 576

JO - Chest

JF - Chest

SN - 0012-3692

IS - 2

ER -